van Geffen, Johanna P.
Swieringa, Frauke
van Kuijk, Kim
Tullemans, Bibian M. E.
Solari, Fiorella A.
Peng, Bing
Clemetson, Kenneth J.
Farndale, Richard W.
Dubois, Ludwig J.
Sickmann, Albert
Zahedi, René P.
Ahrends, Robert
Biessen, Erik A. L.
Sluimer, Judith C.
Heemskerk, Johan W. M.
Kuijpers, Marijke J. E.
Funding for this research was provided by:
Alexander von Humboldt Foundation
de.NBI BMBF initiative grants (031L0108A, 031A534B)
Centre for Translational Molecular Medicine (CTMM), Innovative Coagulation Diagnostics
Cardiovascular Centre (HVC), Maastricht University Medical Centre
Article History
Received: 11 September 2020
Accepted: 23 November 2020
First Online: 8 December 2020
Competing interests
: J.W.H. is founder and co-owner at FlowChamber b.v. R.W.F. is founder of CambCol Laboratories Ltd. Other authors declare no relevant competing interest.